Recently funded by Jeff Dean (Google DeepMind’s former Chief Scientist), Knowtex is already cash-flow positive with 10x revenue growth in 2026 and 300+ customers including the U.S. Department of Veterans Affairs

SAN FRANCISCO, Sept. 15, 2026 — Knowtex today launched the first frontier AI lab for healthcare, building and evaluating clinical AI against real-world standards of accuracy, auditability, and clinician trust. Its first platform, now deployed across the U.S. Department of Veterans Affairs and 300+ other organizations nationwide, turns every patient encounter into accurate notes, correct codes, orders, and real-time actionable clinical intelligence.

“We call ourselves a frontier AI lab because Knowtex is at the edge of what AI can be trusted to do inside a real clinical workflow: coding an oncology chart correctly, understanding a Veteran’s history across decades of care, giving a physician more of the visit back for the patient,” said Caroline Zhang, CEO and co-founder. “That frontier isn’t being pushed by whoever ships the largest foundation model next. It’s being pushed by whoever is closest to the actual clinical edge case, with the technical depth to act on it. That’s what Knowtex has built.”

Clinicians lose hours daily to documentation, coding, and fragmented manual workflows, and US health care administrative spending costs are approximately $1 trillion annually. The Knowtex platform, developed in the Knowtex lab, removes that burden, producing notes, codes, orders, after-visit summaries, and real-time clinical intelligence from each encounter. Health systems gain productivity, more accurate billing, lower clinician burnout, and better patient care.

The Knowtex lab builds specialty-specific models, anti-hallucination safeguards, and an in-house evaluation science for healthcare AI. Its first benchmark, KnowBench, measures Effort Reduction across clinician administrative tasks; the Knowtex platform currently scores 97.99%.

Knowtex’s founders, Caroline Zhang, CEO, and Jocelyn Kang, CTO, met as freshmen at Stanford studying AI and linguistics. They founded Knowtex in 2022 and spent a combined year in scrubs as medical scribes, embedded in healthcare to learn the work firsthand and develop original models and evaluation science built specifically for healthcare.

Knowtex started in oncology, one of the most complex specialties in outpatient medicine, on the bet that a system built to hold up there would generalize everywhere else. Oncology demands exactness in coding, staging, and longitudinal history that general-purpose AI was not built to deliver. Knowtex’s founders, both AI scientists with deep technical expertise, solved those problems at the model and harness level, and that depth is what lets the platform extend across more than 200 specialties today without losing precision.

“Every model we ship is measured against how a clinician would actually judge the output and not just against a generic benchmark,” said Jocelyn Kang, CTO and co-founder. “That is what a lab does. We built the yardstick before we built the product.”

In October 2025, Knowtex was awarded a $15 million contract to deploy its ambient documentation platform across the VA health system, following a competitive evaluation of more than 150 solutions in VA’s AI Tech Sprint for Ambient Scribe.

Since then, Knowtex has deployed across 10 VISNs and 79 VA Medical Centers in the last 6 months – demonstrating historic speed of AI deployment in enterprise healthcare. More than 7,000 clinicians have saved over 450,000 hours of documentation time, with 88% sustained adoption and an average satisfaction rating of 4.5 out of 5 across more than 5,100 ratings.

The VA published an assessment of the Kansas City evaluation, a 90-day review involving 18 primary care providers. According to the VA’s reporting, all 18 participating clinicians wanted to continue using Ambient Scribe technology after the evaluation period, and most reported saving one to two hours of after-hours work. Patient experience scores at the site also rose nearly three percentage points, to 95.8%, over the same period.

“Ambient Scribe has enhanced my patient visits as I can be more focused on my interaction with the Veteran,” one Kansas City VA provider said. “More time talking to patients, more eye contact, more time to use other resources while patients are talking.”

Knowtex is scaling rapidly, with 10x revenue growth and 100x customer growth since the start of 2026. The venture-backed company is already cash-flow positive.

About Knowtex

Knowtex is the first frontier AI lab for healthcare. The lab builds original clinical models and in-house evaluation science for healthcare AI, and its AI-native clinical platform turns every patient encounter into accurate notes, correct codes, orders, and actionable clinical intelligence for providers. Founded by Stanford AI scientists Caroline Zhang and Jocelyn Kang, who spent time embedded in health systems as medical scribes, Knowtex is EHR-agnostic, specialty-customized, and deeply integrated into clinical workflows. It supports more than 200 specialties and is used by leading federal and community health systems, including the U.S. Department of Veterans Affairs. Knowtex is backed by Y Combinator, HF0, Stanford StartX Med, Texas Medical Center Innovation, Jeff Dean, among others, and has been supported by Amazon Web Services (AWS), the UCSF Rosenman Institute, and MedTech Innovators.

Media Contact:
Michelle Faulkner
Big Swing
617-510-6998
[email protected]

SOURCE Knowtex Inc

BOSTON, Sept. 15, 2026 — Artemis Capital Partners (“Artemis” or the “Firm”), a Boston-based private equity firm focused exclusively on partnering with differentiated Industrial Tech companies, today announced the successful final close of Artemis Capital Partners IV, L.P. (“Fund IV” or the “Fund”), with final commitments totaling $254 million.

Fund IV closed on September 1, 2026, marking an important milestone for Artemis and reflecting strong and diverse investor conviction in the Firm’s strategy of buying, building and realizing Industrial Tech platforms that enable mission-critical applications across aerospace, defense, life science and semiconductor end markets.

“We are thrilled to announce the final close of Fund IV and are deeply grateful to our investors for the conviction they have placed in our team, vision, and strategy,” said James Ward, CEO of Artemis. “The successful close of Fund IV reflects the strength of our team’s execution and the confidence our investors have in the opportunity ahead.”

“We are humbled by the continued support of our existing limited partners and excited to welcome many new limited partners to the Artemis partnership,” said Euan Milne, CIO of Artemis. “We are inspired to deliver on that support in the years to come.”

With three Fund IV platforms acquired to date, Artemis continues to execute its specialized strategy of buying, building, and realizing Industrial Tech platforms that enable mission-critical applications across aerospace, defense, life science and semiconductor end markets. Artemis leverages its deep sector authority, demand-first thematic sourcing model and repeatable operational playbook to drive strategic value creation across its Industrial Tech portfolio companies.

The Piper Sandler & Co.’s private capital advisory group, Aviditi Advisors, served as sole placement agent for Fund IV and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. served as legal counsel.

About Artemis

Headquartered in Boston, MA, Artemis is a specialized private equity firm focused on partnering with differentiated Industrial Tech companies, whose people and products enable a healthier, safer, more connected, and productive world. For more information on Artemis, please visit www.artemislp.com.

SOURCE Artemis

Run Ventures leads new funding as recent AI security incidents validate Eve’s early bet
that enterprises need to understand and control autonomous agents while they act

AUSTIN, Texas, Sept. 15, 2026 — Eve Security, the runtime security company built to identify and stop dangerous AI agent behavior in real time, today announced $4.5 million in new funding led by Run Ventures, with participation from Dreamit Ventures and Blu Ventures and continued investment from LiveOak Ventures. This extended seed round brings Eve Security’s total raise to $7.5 million.

The funding marks an important inflection point for Eve. After spending the past year validating its approach to securing AI agents at runtime, the company is seeing growing enterprise demand for technology that can govern what autonomous agents actually do once they are connected to sensitive data, applications and infrastructure. Enterprise customer and investor interest are spiking on the heels of OpenAI’s disclosure that models undergoing a cybersecurity evaluation escaped their testing environment, exploited a previously unknown zero-day to reach the internet and ultimately compromised Hugging Face’s production infrastructure.

“Agents are becoming extraordinarily capable, and enterprises are giving them access to increasingly valuable systems. The OpenAI incident showed what can happen when an agent’s pursuit of an objective takes it somewhere its creators never intended,” said Nadav Cornberg, co-founder and CEO at Eve Security. “You cannot secure that world simply by deciding in advance what an agent should and shouldn’t do. You have to understand what it is doing, why it is doing it and have the ability to intervene while it is happening.”

AI agents represent a fundamentally different security challenge. Traditional cybersecurity tools were built to understand users, identities, endpoints, applications and infrastructure. They can detect a compromised credential, but they were not designed to determine whether a series of individually legitimate actions by an autonomous agent represents reasonable execution of a task or the beginning of dangerous behavior. Eve provides the governance, observability and runtime controls enterprises need to safely deploy those agents, including the ability to interrogate high-risk or anomalous activity and intervene before an agent’s action reaches a critical system.

That approach was reinforced during the fundraising process. RUN.VC introduced Eve to a diverse group of CISOs, whose feedback helped validate both the urgency of the problem and enterprise demand for a new runtime security layer for AI.

“AI runtime security is developing into a significant new security category, and we believe there will be multiple important companies built in this market,” said PT Ungvichian, Run Ventures. “Eve recognized early that securing autonomous systems requires understanding and controlling behavior at runtime, and the company is exceptionally well positioned to capitalize on that shift.”

“We had high conviction in the technical thesis. What we wanted next was market proof,” said Cornberg. “We’re now seeing that pull directly from CISOs and customers. This round lets us put significantly more resources behind turning that early demand into a repeatable business.”

Eve began go-to-market efforts in January, and today its customers are expanding their use of the platform, providing early evidence that runtime agent security is becoming a persistent enterprise requirement rather than a point solution.

Eve is rapidly expanding its platform to secure increasingly complex and autonomous agent deployments. New capabilities include session tainting, which continuously adapts and restricts agent operations based on exposure to sensitive data and prior actions, alongside expanded discovery, enforcement, and automated remediation across Databricks, Glean, Microsoft Copilot Studio, Amazon AgentCore, and Amazon Bedrock. Eve also transforms security policies into a deterministic enforcement layer, allowing more than 85 percent of policy-matched requests to be evaluated and enforced deterministically. For decisions requiring deeper analysis, Eve enriches enforcement with real-time context from identity providers, DLP systems, and data platforms such as Databricks and Snowflake, combining deterministic controls with contextual intelligence for precise runtime governance.

The new funding will primarily accelerate Eve’s go-to-market expansion and revenue growth. Over the next 12 to 18 months, the company intends to demonstrate across multiple enterprise customers that its approach to runtime AI security produces repeatable, measurable results.

About Eve Security

Eve Security provides runtime security and governance for enterprise AI agents. Its Agent-in-the-Loop approach gives organizations real-time visibility into agent activity, automatically interrogates high-risk or anomalous behavior, enriches decisions with enterprise security context and enforces controls before agents take consequential actions. Eve enables enterprises to scale autonomous AI while maintaining the security, governance and accountability required for production environments. Learn more about Eve Security at: https://eve.security/

Media Contact

Jennifer Cloer

503-867-2304

[email protected]

SOURCE Eve Security

Launches Real Estate Debt Investment Platform Brightshore Credit Seeded with $250 Million Investment

NEW YORK, Sept. 15, 2026 — GTIS Partners LP (“GTIS”) today announced it has rebranded as Brightshore Capital LP (“Brightshore”), marking a new chapter for the 21-year old real estate investment firm following its transition to 100% ownership by the firm’s partners. The firm also announced the launch of Brightshore Credit, a real estate debt investment platform anchored with a $250 million investment that will focus on origination and investment in high-yield credit including stretch senior and mezzanine financings, preferred equity and B-notes.

Brightshore manages $5.6 billion in gross assets, with a focus on residential and industrial investments in the US; and residential, industrial, office and hospitality investments in Brazil. The firm was founded in 2005 and the new name follows the 2025 buyout of its minority investment partner’s interest and reflects Brightshore’s evolution as a fully partner-owned investment firm. While the name is new, Brightshore’s leadership, team and investment approach remain unchanged, building on over two decades of real estate investment and development experience. The rebrand establishes an identity that reflects the firm’s current ownership and the next phase of its growth.

“The Brightshore name reflects who we are today: a partner-owned investment firm with over twenty years of experience and a long-term commitment to our investors. With the firm now fully owned by the partners who have built and led the business, this is the right moment to establish an identity that is entirely our own and reflects where we are taking the business next,” said Tom Shapiro, President and Founder of Brightshore Capital.

The rebrand comes as Brightshore has grown its investment platform through several strategic initiatives. In addition to the launch of Brightshore Credit, Brightshore has grown existing platforms in residential, industrial and tax-advantaged real estate investment, executing on several strategies including:

• Continued investment and management of the Brightshore homebuilding and master plan development strategy through its $750 million joint venture with California State Teachers’ Retirement System
• Expansion of its San Francisco multifamily recovery thesis
• Continued expansion of its industrial development and acquisitions with 12 million square feet across the Southeast and Texas accompanied by the formation of a dedicated vehicle
• The launch of its third Opportunity Zones fund, as the firm looks to capitalize on Opportunity Zones’ 2.0 framework after successfully raising $900 million for its previous funds
• The 1.1-million-square-foot development of Campus JK in São Paulo to house Santander Brazil’s corporate headquarters, and investments in logistics, residential and hospitality through its dedicated Brazil investment vehicles

Brightshore’s new ownership structure and expanding investment capabilities position the firm to pursue opportunities with the alignment, flexibility and long-term perspective that have defined it since its founding. The majority of partners have worked together at the firm since its inception and have an average of more than 30 years of real estate experience across multiple economic cycles.

About Brightshore Capital

Brightshore Capital (formerly GTIS Partners) is a real estate investment firm, headquartered in New York with offices in São Paulo, San Francisco, Los Angeles, Atlanta, Charlotte, Houston, and Munich. The firm was founded in 2005 and is managed by President and Founder Tom Shapiro and partners Rob Vahradian, João Teixeira, Tom Feldstein, Ed McDowell, Robert McCall, Peter Ciganik, and Maristella Diniz. The firm manages $5.6 billion in gross assets and is active across a wide range of real estate sectors including single-family and multifamily housing, office, industrial/logistics, hospitality and opportunity zone investments. The firm invests at various points in the capital structure including credit, common equity and structured equity. In the US, Brightshore has invested in over 240 assets across almost 50 unique markets, including growth areas such as San Francisco, New York, Miami, Phoenix, Dallas, Houston, Denver, Atlanta, Tampa, and Charlotte. In Brazil, Brightshore is among the largest real estate private equity firms, with holdings including office, residential, logistics, and hospitality investments. Marquee development assets by the firm in São Paulo include the Infinity office building, Campus JK and hotel Palácio Tangará. For more information, please visit www.brightshore.com.

Media Contacts:

Mary Beth Grover / Keely Gispan
ASC Advisors
(203) 992-1230
[email protected] / [email protected]

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor does it constitute an offer or solicitation of investment advisory services. Any such offer or solicitation may only be made to qualified investors pursuant to definitive offering documents and in compliance with applicable securities laws. Past performance is not indicative of future results.

SOURCE Brightshore Capital

New Unified AI ROI Dashboard bridges the gap between AI usage and financial accountability, providing a centralized view of risk, cost, and adoption.

MOUNTAIN VIEW, Calif., Sept. 15, 2026 — WitnessAI, the AI-native security platform trusted by leading enterprises, today announced the launch of new AI FinOps capabilities within the WitnessAI platform. The latest functionality, anchored with the addition of a Unified AI ROI Dashboard, is designed to help enterprises better understand and control AI spend across employees, models, and agents, and provide measurable data to showcase AI return on investment (ROI).

Enterprise AI adoption has created a new financial-management problem. As AI scales across multiple providers and applications, traditional invoices fail to show who is consuming AI, why, and whether it drives business value. According to WitnessAI’s The Hidden Cost of Enterprise AI report, only 9% of respondents stated that more than three-quarters of their AI initiatives have delivered a measurable financial return, while 33% said AI projects in the last 12 months were always or mostly over budget.

WitnessAI addresses the AI FinOps visibility challenge by operating at the AI traffic and intent layer. The platform connects spend directly to the intent behind the usage, tracking the specific employee, agent, purpose, activity, and model. This contextual visibility enables WitnessAI to combine capabilities that are typically separate, such as multi-provider metering, intelligent model routing, shadow AI discovery, and runtime security. This provides organizations with a single, unified view across three critical lenses: AI risk, cost, and adoption outcomes.

With this release, the WitnessAI platform adds:

• A customizable Unified AI ROI Dashboard: Centralizes AI performance metrics—including risk avoidance, cost savings, and adoption rates—into one dashboard across employees, models, and agents. Organizations can apply configurable ROI multipliers to assign custom dollar values to security incidents prevented, and employee time saved, ensuring the platform reflects an organization’s unique business economics.
• Comprehensive spend visibility and shadow AI discovery: Eliminates enterprise blind spots by automatically discovering unsanctioned AI applications, agents, and MCP servers. The platform accurately estimates shadow AI expenditures while metering sanctioned token consumption across multiple providers, mapping all usage directly to specific teams and business purposes.
• Intelligent routing and pre-inference optimization: Reduces inference costs without sacrificing quality. The platform scores prompts for complexity and business intent, routing tasks to the most cost-effective model. Additionally, pre-inference filtering automatically blocks non-business, off-topic, or abusive prompts before they incur paid token costs.

“With the launch of our new FinOps capabilities, we are changing how organizations think about AI ROI measurement. Instead of treating cost, risk, and adoption as siloed problems, WitnessAI gives leadership a consolidated view of AI economics,” said Rick Caccia, CEO and Founder of WitnessAI. “By translating security events and governance into tangible business terms, we are helping enterprises intelligently route workloads, eliminate shadow AI spend, and reduce waste without restricting the productive AI usage that drives their business forward.”

WitnessAI’s FinOps capabilities are now generally available to all customers. To learn more about the latest features, visit: https://witness.ai/witnessai-for-finops/ 

About WitnessAI 

WitnessAI is the AI security platform enterprises trust to govern and protect all AI activity. We provide complete visibility into every interaction including employees and autonomous agents, even in native apps where legacy tools are blind. Unlike traditional security that relies on outdated keywords, our AI-native platform understands intent, context, and meaning enabling intelligent policies that stop novel threats like prompt injection while empowering productivity. Our enterprise-first, single-tenant architecture ensures data sovereignty and compliance. WitnessAI transforms security from a bottleneck into the enabler of your AI strategy as the confidence layer for enterprise AI.

Media Contact
Katelyn Doherty
[email protected]

SOURCE WitnessAI

Chik brings nearly three decades of enterprise identity leadership and public company board experience to NewCore as enterprises race to secure a workforce of humans and AI agents

TEL AVIV, Israel and SAN FRANCISCO , Sept. 15, 2026 — NewCore, the next-gen IdP for humans and agents, today announced the appointment of Joy Chik to its Board of Directors. Chik brings 28 years of leadership experience, including her most recent role as President of the Identity and Network Access Business at Microsoft. She also serves on the Board of Directors of PayPal Holdings, Inc.

With this appointment, NewCore adds one of the enterprise identity industry’s most recognized executives to its board as the company scales its platform for a workforce of humans, machines, and AI agents.

Chik spent her career at the center of enterprise identity, from the rise of cloud and hybrid environments to the emergence of AI-driven enterprise operations. Over that period, she built and scaled identity infrastructure relied on by hundreds of thousands of organizations worldwide. Since announcing her departure from Microsoft in April 2026, she has focused on public company board service and on partnering with founders and leadership teams as they scale. Her deep technical background and track record of scaling identity programs at global enterprise scale make her a natural fit for NewCore’s mission.

“Joy has spent her career solving the hardest problems in enterprise identity, and she has done it at a scale that very few people in this industry have seen from the inside,” said Zohar Alon, co-founder and CEO of NewCore. “Joy understands identity security and the agentic impact as well as anyone in the industry, and her perspective will sharpen how we build, go to market, and help customers identify, secure, and govern human and agentic identities.”

“Enterprises are entering a new era in which people and AI agents will increasingly work side by side,” said Chik. “To operate securely at scale, organizations need clear ownership for every agent, appropriate access tied to a defined purpose, strong governance, and the ability to maintain accountability as these systems act with greater autonomy. The companies that put those foundations in place now will be best positioned to capture the value of the agentic workforce. I’ve chosen to spend this next chapter working with new startups as they address the challenges facing today’s world, and NewCore is taking a fundamentally new approach to one of the biggest. I’m excited to join the board at a time when the company is helping define what secure identity looks like in the agentic era.”

NewCore emerged from stealth in June 2026 with $66 million in funding from Cyberstarts, Index Ventures, and Evolution Equity Partners. Security innovation is the foundation of NewCore’s approach. Founded by cybersecurity veterans, NewCore rebuilt the identity platform from first principles to reduce risk, eliminate whole classes of identity attacks, and apply defense-grade engineering to every layer of the identity stack. The result is an IdP designed for today’s threat landscape, with strong security and governance for a workforce of humans and agents.

About NewCore

NewCore is the next-gen IdP for humans and agents. Rebuilt from the ground up, it secures, enables, and governs every human and agentic identity under a single, scalable architecture. Founded by cybersecurity veterans and Unit 8200 alumni. Backed by Cyberstarts, Index Ventures, and Evolution Equity Partners. Identity Secured.™

Learn more at newcore.com.

Media Contact

[email protected]

SOURCE NewCore

National Cancer Institute award focuses on the next phase of clinical and product development for Voro

DURHAM, N.C., Sept. 15, 2026 — Levee Medical, a medical device company focused on improving outcomes for men undergoing prostate cancer surgery, today announced that it has been awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

The two-year grant (Grant No. 1R44CA314945-01), effective August 1, 2026, provides approximately $2 million in non-dilutive funding. Selected through NCI’s competitive peer-review process, the project was evaluated for scientific and technical merit, along with its potential impact.

Funding will be used for clinical data collection, investigator training, design control activities and other initiatives supporting continued development of the Voro Urologic Scaffold. The announcement follows the completion of patient enrollment in ARID II, Levee Medical’s multicenter, randomized pivotal trial evaluating the safety and effectiveness of Voro in men undergoing robotic-assisted radical prostatectomy.

“Levee Medical has approached the development and clinical evaluation of the Voro with care and discipline, both in its management of the trial and its engagement with participating investigators,” said Mohummad Minhaj Siddiqui, MD, FACS, Professor and Chief of Urology at the University of Maryland School of Medicine. “This grant creates an opportunity to deepen the evaluation of a novel device and build on the progress already underway. I am encouraged by the company’s thoughtful and responsible approach to the program.”

“We are deeply grateful to NCI and NIH for their support and for the collaborative role federal agencies play in helping promising medical technologies move forward,” said Bruce Choi, Founder and CTO of Levee Medical. “Urinary incontinence after prostatectomy can profoundly affect a man’s quality of life, and there remains significant opportunity to improve recovery outcomes for these patients. This award allows us to broaden our clinical partnerships and continue developing Voro for the men and families affected by this complication.”

The NIH SBIR program helps U.S. small businesses pursue research and development with the potential for commercialization and public benefit. This funding complements Levee Medical’s ongoing PMA program and overall development strategy for the Voro Urologic Scaffold.

About Levee Medical

Levee Medical is dedicated to advancing solutions that aim to reduce complications associated with surgical treatment for prostate cancer. The Voro Urologic Scaffold is the first product Levee Medical plans to bring to market. This device is limited to investigational use and is not approved for commercial use in the United States or any other country.

For more information, visit www.leveemedical.com.

SOURCE Levee Medical

Verlinvest’s investment supports HomeExchange as it turns trust-based travel into a global movement.

NEW YORK, Sept. 15, 2026 — HomeExchange, the world’s largest home swapping platform, has secured a major investment from Verlinvest to accelerate its plan to make home exchanging a mainstream travel solution. The company has built the leading position in a category it pioneered over three decades ago, connecting members in 155 countries through a trust-based, non-monetary exchange model.

With its investment in HomeExchange, Verlinvest, a global, family-backed, consumer-focused evergreen investment firm, makes a meaningful addition to its portfolio of global, fast-growing companies. Verlinvest’s portfolio includes Oatly, Vita Coco, and Tony’s Chocolonely, with alumni including Chewy and Vitaminwater. The investment will support HomeExchange as it scales its global platform and deepens its presence in existing markets, with a particular focus on North America and Western Europe.

Ternel (Capital Croissance), a shareholder and impact investor since 2015 , is renewing its commitment alongside the founders to support this new phase of growth. ISAI, a shareholder since 2021 that supported HomeExchange through its latest growth phase, is exiting its stake as the company enters this new chapter. Co-Founders and co-CEOs Emmanuel Arnaud and Charles-Édouard Girard remain at the helm, both increasing their stake as part of the transaction.

Three decades of disrupting how the world travels
For over 30 years, HomeExchange has connected travelers around the world, exchanging homes instead of money, and rediscovering hospitality in its truest form. In the last year alone, the platform has enabled 2.3 million travelers to complete more than 11.8 million overnight stays. These numbers underscore the scale of the shift toward home exchanging as a mainstream form of travel. 

Emmanuel Arnaud, co-CEO of HomeExchange, said: “Home exchanging has moved from a niche idea to a proven way to travel, and HomeExchange has led that movement from the very beginning. This investment lets us grow it even further. Americans have shown that they’re ready to embrace new consumption models built on sharing rather than ownership. Verlinvest’s support gives us the resources and opportunity to accelerate our growth in the US and in Western Europe, allowing us to bring that experience to even more travelers while staying true to what has made HomeExchange successful.“

A long-term conviction in consumer shifts

Verlinvest was drawn to HomeExchange’s rare combination of scale and loyalty. The firm’s decision to invest reflects its confidence that HomeExchange’s community-first model can expand significantly further without compromising what has made it work.

Raphaël Thiolon, Managing Director at Verlinvest, said: “HomeExchange combines everything we look for at Verlinvest: a unique and innovative product, exceptional loyalty, a market still in its early stages with immense long-term growth potential, and, finally, a remarkable team that shares our ambition to create an iconic global brand. We believe HomeExchange can become one of the major ways people travel and experience hospitality, and we are proud to support Emmanuel and Charles-Edouard as they make that ambition a reality“.

Building a global home exchanging movement

HomeExchange’s ambition for this next chapter is clear: to make home exchanging a mainstream way to travel globally. To get there, the company is focused on three fronts:

• A richer, more seamless experience for every kind of traveler. HomeExchange keeps refining the platform, including a new messaging system and calendar, and is rolling out new filters, like the ability to see at a glance whether a cleaning service is offered.
• Standout offerings that set HomeExchange apart. HomeExchange continues to expand HomeExchange Collection, its curated tier of exceptional homes, alongside new features built for pet owners.
• A larger, more connected community. HomeExchange is growing a member base that already spans 155 countries, with the ambition to strengthen its lead in the markets where it’s already the leader. The United States and Western Europe are the company’s primary growth focus, supported by a dedicated team and local partnerships.

“We have been supporting HomeExchange since 2015, and today we are reinvesting with even greater conviction. This new chapter alongside Verlinvest illustrates our thesis as impact investors: to provide long-term support for business models that combine strong growth with real societal benefits,” emphasizes Mohamed Abdesslam, Managing Partner at Ternel.

“When we invested in 2021, we were convinced that HomeExchange was laying the foundations for a new category of travel. Five years later, that intuition has come to fruition. We are proud to have supported this team throughout this journey,” added Aude Lapillonne, Partner; Pierre Martini, Managing Partner; and Christophe Poupinel, General Partner, ISAI Expansion.

Media contacts
HomeExchange
Jessica Poillucci | [email protected]
Sarah Winston | [email protected] | 413-770-1790 

Verlinvest
[email protected]

About HomeExchange
HomeExchange is the world’s leading home swapping platform. Traveling with HomeExchange means staying in real homes without any financial transaction, based on the principle of reciprocity: each member lends out their home and, in return, is welcomed into another member’s home. Built on a community driven by trust and sharing, the platform enables millions of people to exchange homes each year and lists more than 600,000 homes in 155 countries.

Founded in 1992, HomeExchange was acquired in 2017 by Emmanuel Arnaud and Charles-Édouard Girard, co-founders of GuestToGuest (2011), the platform behind the GuestPoints system, which allows users to exchange homes with greater flexibility, without having to coordinate the availability of two households at the same time.

After acquiring several home exchange platforms between 2013 and 2023—all consolidated under the HomeExchange brand in 2019 — the company launched HomeExchange Collection in 2021, a service dedicated to exceptional homes. A certified B Corp™ since 2022, the company employs over 150 people across France, Croatia, Spain, and the United States.

www.homeexchange.com 

About Verlinvest
Verlinvest is an international, family-backed evergreen investment company. Verlinvest identifies inflection points in consumer behaviors and partners with the businesses driving these consumer revolutions forward while having a positive impact. Established in 1995, with offices in Brussels, London, New York, Singapore, and Mumbai, Verlinvest focuses on the FMCG, health, consumer technology and lifestyle categories, investing across three strategies: Venture, Growth, and Platform — from early-stage backing through large-scale brand building.

The company has over €2.5bn in AuM and counts brands such as Oatly, Vita Coco, Tony’s Chocolonely, Purplle, K1 Speed, Mutti, Who Gives A Crap, and Insomnia Cookies among its portfolio, alongside alumni Chewy, Sula, and Vitaminwater.

Further information is available at www.verlinvest.com

SOURCE HomeExchange

New Decision Intelligence platform examines patterns across conversations and profiles to help people evaluate what the evidence actually supports before deciding what to do next

GEORGETOWN, Ky., Sept. 15, 2026 — Someone responds warmly to a message but never answers the invitation to meet. The conversation continues. Later, another attempt to make plans gets a response, but again, not an answer.

Each message may look perfectly normal on its own. The pattern across them may tell a different story.

That’s the kind of distinction Perscivo was built to examine.

Perscivo is a new Decision Intelligence platform for modern relationships. Users provide conversation text, screenshots or profile information they already possess. The platform analyzes evidence across an interaction and produces a structured Decision Brief identifying patterns, supporting observations, uncertainty, confidence and risk.

“Dating apps have created incredible opportunities for people to meet,” said George Mangos, Founder & CEO of Perscivo. “But once you connect, you still have to figure out what the interaction actually means. Someone responding isn’t necessarily the same as someone answering. Someone being friendly isn’t necessarily the same as a relationship progressing. Perscivo helps you look at the evidence before deciding what to do next.”

That decision is taking place inside a substantial digital economy. Grand View Research estimates the global online dating market at approximately $13 billion in 2026, with subscriptions representing its largest revenue segment. At the same time, major dating platforms maintain dedicated systems to combat fake, spam and otherwise inauthentic accounts, while the Federal Trade Commission reported $1.14 billion in consumer losses from romance scams in 2023.

Perscivo does not attempt to determine whether another person is real or fake, authenticate identities or perform facial recognition. It also does not scrape or require integration with dating platforms.

Instead, it applies structured analysis to the information a user already has. A Decision Brief can identify evidence involving communication, reciprocity, momentum and investment, distinguish observations from assumptions, and explicitly acknowledge when there isn’t enough evidence to reach a confident conclusion.

“We’re not trying to replace dating apps or human judgment,” Mangos said. “We’re trying to give the person making the decision a little more information and a more level playing field before they invest more time, attention, emotion or money.”

Perscivo is available on the web for $14.99 per month following a three-day trial, plus applicable taxes.

Journalists interested in evaluating Perscivo can request product access, review anonymized Decision Briefs, or test the platform using their own sample conversations.

About Perscivo

Perscivo is a Decision Intelligence platform for modern relationships designed to help people distinguish evidence from assumptions, recognize meaningful patterns and uncertainty, and make better-informed decisions about their connections.

Media Contact
George Mangos
Founder & CEO, Perscivo
859-469-3204
[email protected] 
https://perscivo.com/

SOURCE Perscivo LLC